Biotinylated Human HLA-A*03:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein (Monomer, MALS verified)
Cat. No. HLV-H82E9
| Molecule | Cat. No. | Product Name | 種 | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| HLA-A*0301 & B2M & KRASG12V (VVGAVGVGK) | Biotinylated Human HLA-A*03:01&B2M&KRASG12V (VVGAVGVGK) Complex Protein (Monomer, MALS verified) | Human | HEK293 | MALSSDS-PAGE | $125.00 25ug | |||
| HLA-A*0301 & B2M & KRASG12V (VVGAVGVGK) | PE-Labeled Human HLA-A*03:01&B2M&KRASG12V (VVGAVGVGK) Tetramer Protein | Human | HEK293 | $410.00 25ug |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| DNDI-6148 | DNDI-6148 | Phase 1 Clinical | Drugs For Neglected Diseases Initiative | Infections; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral | 詳細 |
| AN-3661 | AN-6426; AN-3661 | Phase 1 Clinical | Anacor Pharmaceuticals Inc | Malaria | 詳細 |